Pfizer, Incorporated Contract Details

Defense contract under the Defense Advanced Research Projects Agency awarded to Pfizer, Incorporated on 12/4/2013.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website ( unless otherwise noted.

Contractor: Pfizer, Incorporated
Department: Defense Advanced Research Projects Agency
Awarded: 12/4/2013

Pfizer, Inc., has been awarded a $7,670,632 technology investment agreement. Pfizer shall perform a research and development program designed to develop a technology platform to identify and subsequently induce the production of protective antibodies to an emerging pathogen directly in an infected or exposed individual. Work will be performed in Cambridge, Mass. The estimated completion date is Dec. 8, 2016. Fiscal 2013 research and development funds are being obligated at time of award. The contracting activity is the Defense Advanced Research Projects Agency, Arlington, Va., (HR0011-14-3-0001).

Total Contract Value: $7,670,632

View all contracts that include "Pfizer, Incorporated" in the MiC database.